BRIEF-Cempra - EMA's CHMP will begin their assessment of Solithromycin By: Reuters: Company News August 23, 2016 at 07:37 AM EDT * Cempra announces European medicines agency validates MAA for solithromycin for treatment of CABP Read More >>